Last reviewed · How we verify
NCT05039541
The ReModel IHC Study for ESRD Patients
NA trial testing Alio Device in Dialysis Access Malfunction in 12 participants. Completed in 20 April 2022.
20 April 2022
Quick facts
| Lead sponsor | Alio, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 12 |
| Start date | 1 March 2022 |
| Primary completion | 20 April 2022 |
| Estimated completion | 20 April 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Alio Device
Conditions studied
- Dialysis Access Malfunction — all drugs for Dialysis Access Malfunction →
Sponsor
Alio, Inc.
Who can join
Adults 18 to 80, any sex, with Dialysis Access Malfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There will be two phases of this study. The phases of this study may occur simultaneously. In Phase I, eligible subjects will be asked to acutely wear the Alio Medical RMS SmartPatch during regularly scheduled dialysis sessions. Subjects will have a pre- and post-dialysis blood draw(s), vitals collected, and monitoring throughout the dialysis sessions. The SmartPatch will be removed from the location(s) where it is placed following the post-dialysis blood draw. In Phase II, subjects will be asked to wear a SmartPatch for up to 90 days. Subjects will be trained on the use of the Alio Medical RMS and be provided a system for them to utilize at home. Patches will be changed at a minimum of once every 7 days.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05039541
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Alio Device
Trials testing the same drug.
- NCT05382663 — The Jordan Study for End-Stage Renal Disease Subjects · NA · recruiting
Other recruiting trials for Dialysis Access Malfunction
Currently open trials in the same condition.
- NCT06553443 — Randomised Clinical Trial Comparing Drug-coated Balloon to Plain Balloon for All Peripheral AVF Stenosis · Phase 3 · recruiting
Other Alio, Inc. trials
Trials by the same sponsor.
- NCT06056739 — Alio WEAR Study: Long-term Wear of the Alio Platform · NA · unknown
- NCT05382663 — The Jordan Study for End-Stage Renal Disease Subjects · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05039541 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Alio, Inc.
- Last refreshed: 22 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05039541.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing